Your browser doesn't support javascript.
loading
MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis.
Musacchio, Lucia; Valsecchi, Anna Amela; Salutari, Vanda; Valabrega, Giorgio; Camarda, Floriana; Tuninetti, Valentina; Giannone, Gaia; Bartoletti, Michele; Marchetti, Claudia; Pignata, Sandro; Fagotti, Anna; Scambia, Giovanni; Di Maio, Massimo; Lorusso, Domenica.
Affiliation
  • Musacchio L; Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Valsecchi AA; Department of Oncology, University of Torino at Ordine Mauriziano Hospital, Turin, Italy.
  • Salutari V; Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Valabrega G; Department of Oncology, University of Torino at Ordine Mauriziano Hospital, Turin, Italy.
  • Camarda F; Comprehensive Cancer Center, Agostino Gemelli University Polyclinic (IRCCS), Rome, Italy.
  • Tuninetti V; Department of Oncology, University of Torino at Ordine Mauriziano Hospital, Turin, Italy.
  • Giannone G; Imperial College London Division of Cancer, Department of Surgery and Cancer, London, United Kingdom.
  • Bartoletti M; Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Italy.
  • Marchetti C; Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.
  • Fagotti A; Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
  • Scambia G; Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
  • Di Maio M; Department of Oncology, University of Torino at Ordine Mauriziano Hospital, Turin, Italy. Electronic address: massimo.dimaio@unito.it.
  • Lorusso D; Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Cancer Treat Rev ; 110: 102458, 2022 Nov.
Article in En | MEDLINE | ID: mdl-36063572
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovary / Peritoneal Neoplasms Type of study: Clinical_trials / Systematic_reviews Limits: Female / Humans Language: En Journal: Cancer Treat Rev Year: 2022 Document type: Article Affiliation country: Italia Country of publication: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovary / Peritoneal Neoplasms Type of study: Clinical_trials / Systematic_reviews Limits: Female / Humans Language: En Journal: Cancer Treat Rev Year: 2022 Document type: Article Affiliation country: Italia Country of publication: Países Bajos